| P50 | author | Karl Deisseroth | Q935993 |
| | Laurie Galvan | Q57780557 |
| P2093 | author name string | Carlos Cepeda | |
| | Michael S Levine | |
| | Véronique M André | |
| | Joseph B Watson | |
| | Jane Y Chen | |
| | Shilpa P Rao | |
| | Sandra M Holley | |
| | Elian P Botelho | |
| P2860 | cites work | Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease | Q37311202 |
| | Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function. | Q37930190 |
| | Optogenetic investigation of neural circuits underlying brain disease in animal models. | Q37994954 |
| | Cortical GABAergic Neurons: Stretching it Remarks, Main Conclusions and Discussion | Q39481569 |
| | Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease | Q39732881 |
| | GABAergic circuits of the striatum. | Q40714703 |
| | Striatal interneurones: chemical, physiological and morphological characterization | Q40991491 |
| | Origin and molecular specification of striatal interneurons. | Q41753651 |
| | Dichotomous organization of the external globus pallidus. | Q42108476 |
| | Dopaminergic Modulation of Axon Collaterals Interconnecting Spiny Neurons of the Rat Striatum | Q42450993 |
| | Direct physiological evidence for synaptic connectivity between medium-sized spiny neurons in rat nucleus accumbens in situ | Q42451693 |
| | Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 |
| | Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice | Q42513638 |
| | Tonic mGluR5/CB1-dependent suppression of inhibition as a pathophysiological hallmark in the striatum of mice carrying a mutant form of huntingtin | Q42517785 |
| | Disrupted GABAAR trafficking and synaptic inhibition in a mouse model of Huntington's disease | Q42550875 |
| | Inhibitory interactions between spiny projection neurons in the rat striatum | Q44121132 |
| | Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease. | Q44306949 |
| | Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons | Q44463501 |
| | Parvalbumin is expressed in glutamatergic and GABAergic corticostriatal pathway in mice | Q45011063 |
| | Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF. | Q45125272 |
| | Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease | Q45291252 |
| | Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice | Q45297144 |
| | A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. | Q45298582 |
| | Hyperactive striatal neurons in symptomatic Huntington R6/2 mice: variations with behavioral state and repeated ascorbate treatment | Q45298941 |
| | Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease | Q45300523 |
| | Dopamine-deprived striatal GABAergic interneurons burst and generate repetitive gigantic IPSCs in medium spiny neurons. | Q45964936 |
| | Functional and molecular development of striatal fast-spiking GABAergic interneurons and their cortical inputs | Q46714630 |
| | Somatostatinergic modulation of firing pattern and calcium-activated potassium currents in medium spiny neostriatal neurons | Q48260625 |
| | Huntington disease | Q48465200 |
| | The neuronal NOS inhibitor L-MIN, but not 7-NINA, reduces neurotoxic effects of chronic intrastriatal administration of quinolinic acid | Q48557587 |
| | Postnatal development of tyrosine hydroxylase mRNA-expressing neurons in mouse neostriatum. | Q48833219 |
| | Comparison of IPSCs evoked by spiny and fast-spiking neurons in the neostriatum. | Q52087677 |
| | Different inhibitory inputs onto neostriatal projection neurons as revealed by field stimulation | Q80542585 |
| | Heterogeneity and diversity of striatal GABAergic interneurons | Q21090474 |
| | Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease | Q24657764 |
| | A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. | Q27860836 |
| | Feedforward and feedback inhibition in neostriatal GABAergic spiny neurons | Q28259633 |
| | Dopaminergic neurons inhibit striatal output through non-canonical release of GABA | Q28276335 |
| | Electrophysiological and morphological characteristics and synaptic connectivity of tyrosine hydroxylase-expressing neurons in adult mouse striatum | Q28282902 |
| | Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease | Q28589793 |
| | Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice | Q29615357 |
| | Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease | Q30490632 |
| | Differential loss of striatal projection neurons in Huntington disease | Q33637273 |
| | Distinct roles of GABAergic interneurons in the regulation of striatal output pathways | Q33720464 |
| | Inhibitory control of neostriatal projection neurons by GABAergic interneurons | Q33861738 |
| | Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington's disease | Q33923206 |
| | Developmental regulation and neuroprotective effects of striatal tonic GABAA currents | Q34007247 |
| | Huntington's disease: the challenge for cell biologists | Q34106564 |
| | Nitric oxide and nitric oxide synthase in Huntington's disease | Q34208531 |
| | Fast synaptic transmission between striatal spiny projection neurons | Q34389712 |
| | Physiology and pharmacology of striatal neurons | Q34607026 |
| | Differential electrophysiological changes in striatal output neurons in Huntington's disease. | Q34764514 |
| | Altered Balance of Activity in the Striatal Direct and Indirect Pathways in Mouse Models of Huntington's Disease | Q35055022 |
| | Selective inhibition of striatal fast-spiking interneurons causes dyskinesias | Q35580745 |
| | Dichotomous anatomical properties of adult striatal medium spiny neurons | Q35607269 |
| | Abnormal burst patterns of single neurons recorded in the substantia nigra reticulata of behaving 140 CAG Huntington's disease mice | Q35774197 |
| | GABAergic microcircuits in the neostriatum | Q35912996 |
| | Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect | Q35913010 |
| | A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease | Q35951187 |
| | Functional diversity and specificity of neostriatal interneurons. | Q35974955 |
| | Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease | Q36101696 |
| | The corticostriatal pathway in Huntington's disease | Q36684263 |
| | Dopaminergic neurons intrinsic to the striatum | Q36730690 |
| | Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice | Q37072467 |
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Huntington's disease | Q190564 |
| | striatum | Q1319792 |
| P304 | page(s) | 7393-7406 | |
| P577 | publication date | 2013-04-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse models | |
| P478 | volume | 33 | |